首页> 美国卫生研究院文献>Clinical Medicine >Valvular Heart Disease: Recommendations for Investigation and Management
【2h】

Valvular Heart Disease: Recommendations for Investigation and Management

机译:瓣膜性心脏病:调查和管理建议

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite the decline of rheumatic fever, valvular heart disease remains a common and important problem. The investigation and treatment of patients have been revolutionised by the widespread availability of echocardiography, which provides information about disease aetiology, accurate and non-invasive assessment of severity and a means of monitoring progression. These advances have facilitated progress in reconstructive valve surgery and the application of balloon valvuloplasty. Improved valve prostheses and reduction in peri-operative mortality have also broadened the indications for valve replacement surgery. A working party convened by the British Cardiac Society and the Royal College of Physicians of London have reviewed current practice and provided guidelines, summarised in this article, for the investigation and management of adults with valvular heart disease in primary care, district general hospitals and tertiary referral centres.
机译:尽管风湿热下降,但瓣膜性心脏病仍然是一个普遍而重要的问题。超声心动图的广泛应用已经彻底改变了患者的调查和治疗方法,超声心动图可提供有关疾病病因,严重程度的准确和非侵入性评估以及监测进展情况的信息。这些进步促进了瓣膜重建术和球囊瓣膜成形术的应用。瓣膜修复的改善和围手术期死亡率的降低也扩大了瓣膜置换手术的适应症。由英国心脏学会和伦敦皇家医师学院召集的一个工作组对当前的实践进行了回顾,并提供了本文总结的指导原则,用于调查和管理初级保健,地区综合医院和三级成年人的瓣膜性心脏病转诊中心。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号